Entity usage
From MaRDI portal
This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.
Showing below up to 1 result in range #1 to #1.
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database: Statement: P12, Statement: P1450, Statement: P200, Statement: P205, Statement: P21, Statement: P225, Statement: P226, Statement: P227, Statement: P27, Statement: P28, Label: en, Miscellaneous (e.g. aliases, entity existence), Sitelink, Title